EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fibroblast growth factor 23 and calcium‐phosphate metabolism in relation to cardiovascular risk factors in patients with type 1 diabetes

Stephanie Vermeulen iD, Mirjam E A Scheffer-Rath, Martine T P Besouw, Amarens van der Vaart, Martin H de Borst, Annemieke M Boot

Journal of Diabetes · 2024-06 · 16 (6)

DOI: 10.1111/1753-0407.13500 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes, online erschienen am 20.12.2023. Verfasst von Stephanie Vermeulen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Neth…. Hauptthemen laut MEDLINE: Fibroblast Growth Factor-23, Diabetes Mellitus, Type 1, Cardiovascular Diseases, Calcium. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cardiovascular disease (CVD) is the major cause of mortality in type 1 diabetes (T1D). The objective of this study is to evaluate fibroblast growth factor 23 (FGF23) and calcium‐phosphate metabolism in relation to cardiovascular risk factors in adults with and without T1D.

Methods

A case–control study was conducted using data from patients with T1D and age‐ and sex matched controls without T1D from the Lifelines Cohort Study.

Results

We included 302 adults in the T1D group and 302 adults in the control group. Median age was 42 years. Median glycosylated hemoglobin (HbA1c) in the T1D group was 7.8%. FGF23 of all patients with T1D was not significantly different from controls. Females with T1D had significantly higher FGF23 than males with T1D (83.3 vs 69.3 U/mL, p = 0.002), this was not observed in controls. Serum phosphate, calcium, and alkaline phosphatase were higher and parathyroid hormone was lower in patients with T1D, compared to controls (all p < .001), all within normal range. In the T1D group, FGF23 was positively correlated with serum phosphate ( p < .001), alkaline phosphatase ( p = .01), and calcium ( p = .030), these correlations were not observed in controls. Median FGF23 was significantly higher in current smokers than in nonsmokers with T1D (84.9 vs 73.5 U/mL, p < .05).

Conclusions

Serum calcium, phosphate, and alkaline phosphatase were higher in patients with T1D than in controls and were positively correlated to FGF23 in patients with T1D. Current smokers with T1D had higher FGF23 than nonsmokers with T1D. These findings may contribute to the increased risk of CVD in patients with T1D. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Growth Factor-23Diabetes Mellitus, Type 1Cardiovascular DiseasesCalciumHeart Disease Risk FactorsHumansMaleFemaleAdultCase-Control StudiesMiddle AgedFibroblast Growth FactorsPhosphatesRisk FactorsGlycated HemoglobinBiomarkers

Stichwörter der Autor:innen

FGF23calciumdiabetes mellitus type 1phosphatesmoking

Substanzen

Fibroblast Growth Factor-23FGF23 protein, humanCalciumFibroblast Growth FactorsPhosphatesGlycated HemoglobinBiomarkers

Autor:innen und Institutionen

  • Department of Pediatric Endocrinology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Diabeter Center for Pediatric and Adolescent Diabetes Care and Research, Groningen, the Netherlands.
  • Department of Pediatrics, Rijnstate Hospital, Arnhem, the Netherlands.
  • Department of Pediatric Nephrology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Department of Internal Medicine, Division of Endocrinology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

ORCID-Profile: Stephanie Vermeulen

Zitieren

APA

Vermeulen, S., Scheffer-Rath, M. E. A., Besouw, M. T. P., van der Vaart, A., de Borst, M. H., & Boot, A. M. (2024). Fibroblast growth factor 23 and calcium‐phosphate metabolism in relation to cardiovascular risk factors in patients with type 1 diabetes. Journal of Diabetes, 16(6). https://doi.org/10.1111/1753-0407.13500

Vancouver

Vermeulen S, Scheffer-Rath MEA, Besouw MTP, van der Vaart A, de Borst MH, Boot AM. Fibroblast growth factor 23 and calcium‐phosphate metabolism in relation to cardiovascular risk factors in patients with type 1 diabetes. Journal of Diabetes. 2024;16(6). doi:10.1111/1753-0407.13500

BibTeX
@article{Vermeulen2024,
  author = {Vermeulen, Stephanie and Scheffer-Rath, Mirjam E A and Besouw, Martine T P and van der Vaart, Amarens and de Borst, Martin H and Boot, Annemieke M},
  title = {Fibroblast growth factor 23 and calcium‐phosphate metabolism in relation to cardiovascular risk factors in patients with type 1 diabetes},
  journal = {Journal of Diabetes},
  year = {2024},
  volume = {16},
  number = {6},
  doi = {10.1111/1753-0407.13500}
}
Kostenlos starten →